Mari S. Oba

2.0k total citations
103 papers, 1.3k citations indexed

About

Mari S. Oba is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mari S. Oba has authored 103 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 18 papers in Surgery. Recurrent topics in Mari S. Oba's work include Venous Thromboembolism Diagnosis and Management (9 papers), Cancer Treatment and Pharmacology (9 papers) and Gastric Cancer Management and Outcomes (8 papers). Mari S. Oba is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Cancer Treatment and Pharmacology (9 papers) and Gastric Cancer Management and Outcomes (8 papers). Mari S. Oba collaborates with scholars based in Japan, United States and Germany. Mari S. Oba's co-authors include Yoshitaka Murakami, Satoshi Morita, Shigeru Aoki, Fumiki Hirahara, Yuji Nishiwaki, Satoko Ohfuji, Yasuo Suzuki, Yasuo Ohashi, Keiko Asakura and Wakaba Fukushima and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Environmental Health Perspectives.

In The Last Decade

Mari S. Oba

97 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mari S. Oba

Since Specialization

Citations

This map shows the geographic impact of Mari S. Oba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari S. Oba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari S. Oba more than expected).

Fields of papers citing papers by Mari S. Oba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari S. Oba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari S. Oba. The network helps show where Mari S. Oba may publish in the future.

Co-authorship network of co-authors of Mari S. Oba

This figure shows the co-authorship network connecting the top 25 collaborators of Mari S. Oba. A scholar is included among the top collaborators of Mari S. Oba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari S. Oba. Mari S. Oba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Effects of Annual Intensive Rehabilitation in Patients with Hereditary Pure Cerebellar Ataxia: A 7-year Follow-up Study 2025 ·The Cerebellum ·(unknown), Yuki Kondo, (unknown), (unknown), Mari S. Oba, Takatoshi Hara, Yūji Takahashi	0
2	Anti-mitochondrial M2 antibody-positive myositis may be an independent subtype of autoimmune myositis 2025 ·Journal of Neurology ·(unknown), Jantima Tanboon, Munenori Oyama, (unknown), (unknown), Mari S. Oba, (unknown), Kazuma Sugie, Shigeaki Suzuki, Shinichiro Hayashi, S. Noguchi, Ichizo Nishino	0
3	A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer 2024 ·Breast Cancer ·Kumiko Kida, Akimitsu Yamada, Kazuhiro Shimada, Kazutaka Narui, Sadatoshi Sugae, Daisuke Shimizu, (unknown), Mari S. Oba, Itaru Endo, Takashi Ishikawa	5
4	Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial) 2023 ·Breast Cancer Research and Treatment ·(unknown), Naoki Niikura, Yuichiro Kikawa, Mari S. Oba, Kokoro Kobayashi, Hiroshi Tada, Shinji Ozaki, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Toshitaka Okuno, Nobutaka Iwakuma, Takashi Takeshita, Takayuki Iwamoto, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji	2
5	Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort 2023 ·Journal of Gastroenterology ·Takuji Okusaka, Akio Saiura, Kazuaki Shimada, Masafumi Ikeda, Tatsuya Ioka, Tetsuya Kimura, (unknown), Atsushi Takita, Mari S. Oba	5
6	Impact of renal and hepatic function on first opioid prescriptions in cancer patients: an acute care hospital database study linked to medical claims data and laboratory data 2023 ·Japanese Journal of Clinical Oncology ·(unknown), Mitsunori Miyashita, Mari S. Oba, Yoshitaka Murakami	1
7	Impact of the Clinical Trials Act 2018 on clinical trial activity in Japan from 2018 to 2020: a retrospective database study using new and conventional Japanese registries 2022 ·BMJ Open ·(unknown), Mari S. Oba, Osamu Takizawa, (unknown), (unknown), Mayumi Shikano	3
8	Maternal Metals Exposure and Infant Weight Trajectory: The Japan Environment and Children’s Study (JECS) 2022 ·Environmental Health Perspectives ·Yu Taniguchi, Shin Yamazaki, Shoji F. Nakayama, Makiko Sekiyama, Takehiro Michikawa, Tomohiko Isobe, Miyuki Iwai‐Shimada, Yayoi Kobayashi, Hiroshi Nitta, Mari S. Oba, Michihiro Kamijima, (unknown)	12
9	Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: A retrospective cohort study 2022 ·Brain and Development ·Yuko Shimizu‐Motohashi, (unknown), Katsuhiro Mizuno, Hiroyuki Yajima, Akihiko Ishiyama, Eri Takeshita, (unknown), Mari S. Oba, Masayuki Sasaki, Shuichi Ito, Hirofumi Komaki	10
10	228P Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial) 2022 ·Annals of Oncology ·(unknown), Naoki Niikura, Yuichiro Kikawa, Mari S. Oba, Kokoro Kobayashi, Hiroyuki Tada, (unknown), Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Toshitaka Okuno, Nobutaka Iwakuma, Takashi Takeshita, Takayuki Iwamoto, Hiroshi Ishiguro, (unknown), Shigehira Saji	1
11	One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry 2021 ·Thrombosis Research ·Yasuo Ohashi, Masataka Ikeda, Hideo Kunitoh, Mitsuru Sasako, Takuji Okusaka, Hirofumi Mukai, Keiichi Fujiwara, Mashio Nakamura, Mari S. Oba, Tetsuya Kimura, (unknown), Atsushi Takita, Masato Sakon	16
12	Neoadjuvant Chemotherapy With Anthracycline-Based Regimen for BRCAness Tumors in Triple-Negative Breast Cancer 2020 ·Journal of Surgical Research ·(unknown), Eiichi Sato, Kazutaka Narui, Akimitsu Yamada, Tomoyuki Fujita, Kimito Yamada, Mari S. Oba, Takashi Ishikawa	5
13	The effect of TJ-28 (Eppikajutsuto) on the prevention of hand-foot syndrome using Capecitabine for colorectal cancer: The Yokohama Clinical Oncology Group Study (YCOG1102) 2020 ·Indian Journal of Gastroenterology ·Kazuteru Watanabe, Atsushi Ishibe, Jun Watanabe, Mitsuyoshi Ota, Shoichi Fujii, Yasushi Ichikawa, Mari S. Oba, Itaru Endo	7
14	Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07) 2018 ·BMC Nephrology ·Tomoko Horinouchi, Mayumi Sako, Koichi Nakanishi, Kenji Ishikura, Shuichi Ito, Hidefumi Nakamura, Mari S. Oba, Kandai Nozu, Kazumoto Iijima	10
15	A Randomized Controlled Trial of Vildagliptin Versus Alogliptin: Effective Switch From Sitagliptin in Patients With Type 2 Diabetes 2017 ·Journal of Clinical Medicine Research ·(unknown), Tadashi Yamakawa, Mari S. Oba, Jun Suzuki, (unknown), Kazuaki Kadonosono, Yasuo Terauchi	8
16	Predicting outcomes of neonates born to GBS-positive women who received inadequate intrapartum antimicrobial prophylaxis. 2016 ·PubMed ·Katsuaki Kojima, Ryuma Tanaka, Keisuke Nakajima, (unknown), Mari S. Oba, (unknown), (unknown), (unknown)	4
17	Effect of Umbilical Cord Entanglement and Position on Pregnancy Outcomes 2015 ·Obstetrics and Gynecology International ·Natsuko Kobayashi, Shigeru Aoki, Mari S. Oba, Tsuneo Takahashi, Fumiki Hirahara	17
18	Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement 2014 ·Journal of obstetrics and gynaecology research ·(unknown), Shigeru Aoki, Mari S. Oba, Kentaro Kurasawa, Tetsu Takahashi, Fumiki Hirahara	67
19	Modified Pulmonary Index Score Was Sufficiently Reliable to Assess the Severity of Acute Asthma Exacerbations in Children 2014 ·Allergology International ·(unknown), Mari S. Oba, Toshio Katsunuma, Akira Ishiguro, Yukihiro Ohya, Hidefumi Nakamura	12
20	Comparison of LogMAR Eye charts with angular vision for visually impaired: the Berkeley rudimentary vision test vs LogMAR One target Landolt ring Eye chart 2013 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·(unknown), (unknown), Mari S. Oba, Nobuhisa Mizuki, Tomomi Nishida	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact